Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The evolution of imaging techniques for multiple myeloma

Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy
The evolution of imaging techniques for multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )
2 May 2018

Managing infections in patients with multiple myeloma

Dr Joan Bladé - Hospital Clínic Barcelona, Barcelona, Spain
Managing infections in patients with multiple myeloma ( Dr Joan Bladé - Hospital Clínic Barcelona, Barcelona, Spain )
2 May 2018

Treating bone disease in multiple myeloma patients

Dr John Ashcroft - Mid Yorkshire Hospitals NHS Trust, Wakefield, UK
Treating bone disease in multiple myeloma patients ( Dr John Ashcroft - Mid Yorkshire Hospitals NHS Trust, Wakefield, UK )
2 May 2018

Incorporating patient perspective during myeloma treatment

Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK
Incorporating patient perspective during myeloma treatment ( Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK )
2 May 2018

Dealing with peripheral neuropathic pain in multiple myeloma

Prof Wolfgang Grisold - Ludwig Boltzmann Gesellschaft, Vienna, Austria
Dealing with peripheral neuropathic pain in multiple myeloma ( Prof Wolfgang Grisold - Ludwig Boltzmann Gesellschaft, Vienna, Austria )
2 May 2018

Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018

Biomarkers of pembrolizumab response in head and neck cancer

Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA
Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )
25 Apr 2018

A variety of approaches to measure the efficacy of PARP inhibitors

Dr Elisabetta Leo - AstraZeneca, Cambridge, UK
A variety of approaches to measure the efficacy of PARP inhibitors ( Dr Elisabetta Leo - AstraZeneca, Cambridge, UK )
25 Apr 2018

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA
Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy ( Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA )
25 Apr 2018

First-in-human trial results of RET targeted BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018

Treating RET alterations with novel therapy BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018